Package 47781-637-30

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 47781-637-30
Digits Only 4778163730
Product NDC 47781-637
Product ID 47781-637_e6291f65-f3fd-7567-c756-ce326933a2ec
Description

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-637-30)

Marketing

Marketing Status
Discontinued 2026-03-01
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

bupropion hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e6291f65-f3fd-7567-c756-ce326933a2ec", "openfda": {"upc": ["0347781637309"], "unii": ["ZG7E5POY8O"], "rxcui": ["1232585"], "spl_set_id": ["a032e7c8-33f2-5fdb-62d7-8517072d1d10"], "manufacturer_name": ["Alvogen Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-637-30)", "package_ndc": "47781-637-30", "marketing_end_date": "20260301", "marketing_start_date": "20180928"}], "brand_name": "bupropion hydrochloride", "product_id": "47781-637_e6291f65-f3fd-7567-c756-ce326933a2ec", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "47781-637", "generic_name": "bupropion hydrochloride", "labeler_name": "Alvogen Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "450 mg/1"}], "application_number": "NDA022497", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20260301", "marketing_start_date": "20180928"}